The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Opioid Induced Constipation Treatment Market Research Report 2024
Synopsis
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
The global Opioid Induced Constipation Treatment market was valued at US$ 1427.9 million in 2023 and is anticipated to reach US$ 2354.5 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
This report aims to provide a comprehensive presentation of the global market for Opioid Induced Constipation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Constipation Treatment.
Report Scope
The Opioid Induced Constipation Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioid Induced Constipation Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Induced Constipation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
Segment by Type
Oral
Parenteral (Subcutaneous Injection)
Segment by Application
Drug Store
Hospital Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Induced Constipation Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
The global Opioid Induced Constipation Treatment market was valued at US$ 1427.9 million in 2023 and is anticipated to reach US$ 2354.5 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.
Global Opioid-Induced Constipation key players include Sanofi, Bayer, Purdue Pharm, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.
In terms of product, Lubiprostone is the largest segment, with a share about 5%. And in terms of application, the largest application is Pharmacy, followed by Hospital, etc.
This report aims to provide a comprehensive presentation of the global market for Opioid Induced Constipation Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Constipation Treatment.
Report Scope
The Opioid Induced Constipation Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioid Induced Constipation Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Induced Constipation Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
Segment by Type
Oral
Parenteral (Subcutaneous Injection)
Segment by Application
Drug Store
Hospital Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Induced Constipation Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Induced Constipation Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Parenteral (Subcutaneous Injection)
1.3 Market by Application
1.3.1 Global Opioid Induced Constipation Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Constipation Treatment Market Perspective (2019-2030)
2.2 Opioid Induced Constipation Treatment Growth Trends by Region
2.2.1 Global Opioid Induced Constipation Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Opioid Induced Constipation Treatment Historic Market Size by Region (2019-2024)
2.2.3 Opioid Induced Constipation Treatment Forecasted Market Size by Region (2025-2030)
2.3 Opioid Induced Constipation Treatment Market Dynamics
2.3.1 Opioid Induced Constipation Treatment Industry Trends
2.3.2 Opioid Induced Constipation Treatment Market Drivers
2.3.3 Opioid Induced Constipation Treatment Market Challenges
2.3.4 Opioid Induced Constipation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Constipation Treatment Players by Revenue
3.1.1 Global Top Opioid Induced Constipation Treatment Players by Revenue (2019-2024)
3.1.2 Global Opioid Induced Constipation Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Opioid Induced Constipation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Opioid Induced Constipation Treatment Revenue
3.4 Global Opioid Induced Constipation Treatment Market Concentration Ratio
3.4.1 Global Opioid Induced Constipation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Constipation Treatment Revenue in 2023
3.5 Opioid Induced Constipation Treatment Key Players Head office and Area Served
3.6 Key Players Opioid Induced Constipation Treatment Product Solution and Service
3.7 Date of Enter into Opioid Induced Constipation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Induced Constipation Treatment Breakdown Data by Type
4.1 Global Opioid Induced Constipation Treatment Historic Market Size by Type (2019-2024)
4.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Type (2025-2030)
5 Opioid Induced Constipation Treatment Breakdown Data by Application
5.1 Global Opioid Induced Constipation Treatment Historic Market Size by Application (2019-2024)
5.2 Global Opioid Induced Constipation Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Opioid Induced Constipation Treatment Market Size (2019-2030)
6.2 North America Opioid Induced Constipation Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Opioid Induced Constipation Treatment Market Size by Country (2019-2024)
6.4 North America Opioid Induced Constipation Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Opioid Induced Constipation Treatment Market Size (2019-2030)
7.2 Europe Opioid Induced Constipation Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Opioid Induced Constipation Treatment Market Size by Country (2019-2024)
7.4 Europe Opioid Induced Constipation Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Opioid Induced Constipation Treatment Market Size (2019-2030)
8.2 Asia-Pacific Opioid Induced Constipation Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Opioid Induced Constipation Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Opioid Induced Constipation Treatment Market Size (2019-2030)
9.2 Latin America Opioid Induced Constipation Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Opioid Induced Constipation Treatment Market Size by Country (2019-2024)
9.4 Latin America Opioid Induced Constipation Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Opioid Induced Constipation Treatment Market Size (2019-2030)
10.2 Middle East & Africa Opioid Induced Constipation Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Opioid Induced Constipation Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Opioid Induced Constipation Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Opioid Induced Constipation Treatment Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Opioid Induced Constipation Treatment Introduction
11.2.4 AstraZeneca Revenue in Opioid Induced Constipation Treatment Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Opioid Induced Constipation Treatment Introduction
11.3.4 Pfizer Revenue in Opioid Induced Constipation Treatment Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 S.L.A. Pharma
11.4.1 S.L.A. Pharma Company Detail
11.4.2 S.L.A. Pharma Business Overview
11.4.3 S.L.A. Pharma Opioid Induced Constipation Treatment Introduction
11.4.4 S.L.A. Pharma Revenue in Opioid Induced Constipation Treatment Business (2019-2024)
11.4.5 S.L.A. Pharma Recent Development
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Detail
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid Induced Constipation Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid Induced Constipation Treatment Business (2019-2024)
11.5.5 AIKO Biotechnology Recent Development
11.6 Cubist Pharmaceuticals
11.6.1 Cubist Pharmaceuticals Company Detail
11.6.2 Cubist Pharmaceuticals Business Overview
11.6.3 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Introduction
11.6.4 Cubist Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2019-2024)
11.6.5 Cubist Pharmaceuticals Recent Development
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Detail
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Opioid Induced Constipation Treatment Introduction
11.7.4 Salix Pharmaceuticals Revenue in Opioid Induced Constipation Treatment Business (2019-2024)
11.7.5 Salix Pharmaceuticals Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Detail
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Opioid Induced Constipation Treatment Introduction
11.8.4 Takeda Pharmaceutical Revenue in Opioid Induced Constipation Treatment Business (2019-2024)
11.8.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
